On Monday December 13, the United States — through the United States Agency for International Development (USAID) — delivered an additional 153,000 doses of the Pfizer vaccine to Tajikistan, according to the U.S. Embassy in Dushanbe.
Later this week another shipment of 146,520 doses will arrive for a total donation of 299,520 doses this week.
These deliveries have been made possible through COVAX, a global initiative to support equitable access to COVID-19 vaccines. This week’s deliveries bring the total U.S. government donation of Pfizer (823,680) and Moderna (1,622,500) vaccine doses in Tajikistan to 2,446,180.
Since March 2020, the United States has provided more than $12 million in equipment and technical support to help the Tajikistan fight against COVID-19. This support has been used to procure medical supplies and personal protective equipment, upgrade laboratories, train public health and medical professionals as well as support vaccination efforts in Tajikistan. The United States will continue partnering with Tajikistan to end the COVID-19 pandemic, mitigate its devastating social and economic impacts and improve preparedness to respond to future outbreaks.
Yesterday’s Pfizer vaccine delivery to Tajikistan is part of the U.S. government’s commitment to donate 1.1 billion of COVID-19 vaccines to the countries most in need — safely, equitably, and with no strings attached. To date, USAID has provided US$5.7 billion to provide vaccines worldwide, with more on the way.
Noting the success of Tajikistan’s vaccine campaign that has already reached more than 40 percent of the country, USAID/Tajikistan Mission Director Peter Riley commented, “We are committed to ensuring Tajikistan reaches 70 percent full vaccination coverage by next September under the Biden Administration’s initiative of Vaccinate the World.”
USAID is the world’s premier international development agency and a catalytic actor driving development results.
